ClinVar Genomic variation as it relates to human health
NM_000484.4(APP):c.2143G>A (p.Val715Met)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000484.4(APP):c.2143G>A (p.Val715Met)
Variation ID: 18097 Accession: VCV000018097.5
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 21q21.3 21: 25891790 (GRCh38) [ NCBI UCSC ] 21: 27264102 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 20, 2014 Feb 14, 2024 Aug 2, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000484.4:c.2143G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000475.1:p.Val715Met missense NM_001136016.3:c.2071G>A NP_001129488.1:p.Val691Met missense NM_001136129.3:c.1750G>A NP_001129601.1:p.Val584Met missense NM_001136130.3:c.1975G>A NP_001129602.1:p.Val659Met missense NM_001136131.3:c.1813G>A NP_001129603.1:p.Val605Met missense NM_001204301.2:c.2089G>A NP_001191230.1:p.Val697Met missense NM_001204302.2:c.2032G>A NP_001191231.1:p.Val678Met missense NM_001204303.2:c.1864G>A NP_001191232.1:p.Val622Met missense NM_001385253.1:c.1975G>A NP_001372182.1:p.Val659Met missense NM_201413.3:c.2086G>A NP_958816.1:p.Val696Met missense NM_201414.3:c.1918G>A NP_958817.1:p.Val640Met missense NC_000021.9:g.25891790C>T NC_000021.8:g.27264102C>T NG_007376.2:g.284339G>A P05067:p.Val715Met - Protein change
- V715M, V622M, V640M, V678M, V584M, V691M, V697M, V605M, V659M, V696M
- Other names
- -
- Canonical SPDI
- NC_000021.9:25891789:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
APP | No evidence available | Sufficient evidence for dosage pathogenicity |
GRCh38 GRCh37 |
462 | 573 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
May 5, 2023 | RCV000019724.34 | |
Likely pathogenic (2) |
criteria provided, single submitter
|
Jun 23, 2017 | RCV000084570.5 | |
Pathogenic (1) |
criteria provided, single submitter
|
Aug 2, 2023 | RCV003509483.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 05, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Alzheimer disease type 1
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
unknown
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV003925659.1
First in ClinVar: May 20, 2023 Last updated: May 20, 2023 |
Comment:
Criteria applied: PS3,PS4_MOD,PM1,PM5,PM2_SUP,PP3
Clinical Features:
Alzheimer disease (present) , Dementia (present)
Sex: female
|
|
Likely pathogenic
(Jun 23, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Athena Diagnostics
Accession: SCV000612389.1
First in ClinVar: Feb 20, 2014 Last updated: Feb 20, 2014 |
|
|
Pathogenic
(Mar 21, 2023)
|
criteria provided, single submitter
Method: research
|
Alzheimer disease type 1
Affected status: yes
Allele origin:
germline
|
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University
Accession: SCV003932785.1
First in ClinVar: Jun 24, 2023 Last updated: Jun 24, 2023 |
Comment:
This case has this variant as heterozygous
Number of individuals with the variant: 1
Age: 40-49 years
Sex: female
Ethnicity/Population group: Caucasian
Geographic origin: Anatolian Peninsula
|
|
Pathogenic
(Aug 02, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Alzheimer disease
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004297369.1
First in ClinVar: Feb 14, 2024 Last updated: Feb 14, 2024 |
Comment:
This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is … (more)
This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 715 of the APP protein (p.Val715Met). This missense change has been observed in individuals with early-onset Alzheimer disease (PMID: 10441572, 18437002; Invitae). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects APP function (PMID: 10097173, 11487570, 20452985). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt APP protein function. ClinVar contains an entry for this variant (Variation ID: 18097). (less)
|
|
Pathogenic
(Sep 01, 1999)
|
no assertion criteria provided
Method: literature only
|
ALZHEIMER DISEASE, FAMILIAL, 1
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000040022.3
First in ClinVar: Apr 04, 2013 Last updated: May 21, 2018 |
Comment on evidence:
In affected members of a family with early-onset AD (104300), Ancolio et al. (1999) identified a mutation in the APP gene, resulting in a val715-to-met … (more)
In affected members of a family with early-onset AD (104300), Ancolio et al. (1999) identified a mutation in the APP gene, resulting in a val715-to-met (V715M) substitution. Overexpression of V715M in human HEK293 cells and murine neurons reduced total A-beta production and increased the recovery of the physiologically secreted product, APP-alpha. The V715M mutation significantly reduced A-beta-40 secretion without affecting A-beta-42 production in HEK293 cells. However, a marked increase in N-terminally truncated A-beta ending at position 42 was observed, whereas its counterpart ending at position 40 was not affected. These results suggested that, in some cases, familial AD may be associated with a reduction in the overall production of A-beta, but may be caused by increased production of truncated forms of A-beta ending at position 42. This family with the V715M mutation was also reported by Campion et al. (1999), the same family having been ascertained through a population-based survey of early-onset Alzheimer disease. (less)
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
VIB Department of Molecular Genetics, University of Antwerp
Accession: SCV000116706.1
First in ClinVar: Feb 20, 2014 Last updated: Feb 20, 2014
Comment:
http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg18&id=ADM_71
|
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease. | Guzmán EA | Molecular neurodegeneration | 2014 | PMID: 24694184 |
Blepharospasm in familial AD secondary to an APP mutation (V715M). | Nan SJ | Acta neurologica Belgica | 2014 | PMID: 24677022 |
Familial Alzheimer's mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site. | Chen W | Nature communications | 2014 | PMID: 24390130 |
Comparable dimerization found in wildtype and familial Alzheimer's disease amyloid precursor protein mutants. | So PP | American journal of neurodegenerative disease | 2013 | PMID: 23515184 |
Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. | Munter LM | The Journal of biological chemistry | 2010 | PMID: 20452985 |
Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer's disease. | Park HK | Journal of Korean medical science | 2008 | PMID: 18437002 |
Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. | De Jonghe C | Human molecular genetics | 2001 | PMID: 11487570 |
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. | Campion D | American journal of human genetics | 1999 | PMID: 10441572 |
Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. | Ancolio K | Proceedings of the National Academy of Sciences of the United States of America | 1999 | PMID: 10097173 |
Text-mined citations for rs63750734 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.